SS
MGRX icon

Sunbelt Securities’s Mangoceuticals MGRX Stock Holding History

Sunbelt Securities’s Portfolio MGRX Stock Details MGRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.32K Hold
12,000
– – ﹤0.01% 1721
2025
Q4 		$8.88K Buy
12,000
+5,000
+71% +$8.11K ﹤0.01% 1471
2025
Q3 		$15.3K Buy
+7,000
New +$13K ﹤0.01% 1336

Other funds holding MGRX

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
VF
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
BFM
Boothbay Fund Management New York $7.71B AUM 106.29% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
ACA
Ackerman Capital Advisors Dallas, Texas $497M AUM 16.31% 1-Year Est. Return
SG
StoneX Group New York $2.48B AUM 33.54% 1-Year Est. Return

Sunbelt Securities's MGRX Position: Q1 2026 in Review

Sunbelt Securities held its Mangoceuticals (MGRX) position steady in Q1 2026 at 12,000 shares worth $4.32K. The position accounts for ﹤0.01% of the portfolio, ranked #1721.

Sunbelt Securities first reported a position in MGRX in Q3 2025 and has held it in 3 quarters since. The position peaked at $15.3K in Q3 2025. 18 funds tracked by Wall St. Rank hold MGRX as of Q1 2026.

  • Sunbelt Securities held 12,000 shares of Mangoceuticals worth $4.32K as of Q1 2026.
  • Sunbelt Securities left its Mangoceuticals share count unchanged in Q1 2026.
  • Mangoceuticals made up ﹤0.01% of Sunbelt Securities's portfolio in Q1 2026, its #1721 holding.
  • Sunbelt Securities first reported a position in Mangoceuticals in Q3 2025 and has held it in 3 quarters since.
  • Sunbelt Securities's Mangoceuticals position peaked at $15.3K in Q3 2025.
  • 18 funds tracked by Wall St. Rank held Mangoceuticals as of Q1 2026.

Based on Sunbelt Securities's 13F filing for Q1 2026, filed 18 May 2026.